Adis Journals
Browse

Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: Efficacy, Safety, and Expert Opinion on Use in Clinical Practice

Download (51.53 MB)
media
posted on 2023-07-17, 15:30 authored by Adis journals on behalf of, Melissa Gooderham, Andrew E. Pink, Eric L. Simpson, Jonathan IS Silverberg, Erman Guler, Melissa Watkins

  

The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.

The above video abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite). 

History

Usage metrics

    Dermatology and Therapy

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC